L. Ekerljung

Effects of HER2-Binding Affibody Molecules on Intracellular Signaling Pathways

J. Carlsson, J. Lennartsson, Ann-Charlott Steffen, 2006, Tumor Biology.

Dimeric HER2-specific affibody molecules inhibit proliferation of the SKBR-3 breast cancer cell line.

J. Carlsson, J. Lennartsson, F. Frejd, 2008, Biochemical and biophysical research communications.

Radiation Induced DNA-Damage/Repair and Associated Signaling Pathways

B. Stenerlöw, J. Carlsson, J. Lennartsson, 2008 .

EGFR- and HER2-Binding Affibody Molecules : Cellular studies of monomeric, dimeric and bispecific ligands

L. Ekerljung, Lina Ekerljung, 2011 .

Analyzing alpha emitting isotopes of Pu, Am and Cm from NPP water samples: an intercomparison of Nordic radiochemical laboratories

X. Hou, A. Vesterlund, H. Ramebäck, 2021, Journal of Radioanalytical and Nuclear Chemistry.

Engineering and characterization of a bispecific HER2 × EGFR‐binding affibody molecule

Fredrik Y Frejd, Helene Andersson-Svahn, Sara Lindström, 2009, Biotechnology and applied biochemistry.

Generation and evaluation of bispecific affibody molecules for simultaneous targeting of EGFR and HER2.

S. Ståhl, F. Frejd, L. Gedda, 2012, Bioconjugate chemistry.

Effects of an EGFR-binding affibody molecule on intracellular signaling pathways.

J. Carlsson, J. Lennartsson, B. Glimelius, 2010, International journal of oncology.

The HER2-Binding Affibody Molecule (ZHER2∶342)2 Increases Radiosensitivity in SKBR-3 Cells

J. Lennartsson, L. Gedda, L. Ekerljung, 2012, PloS one.